Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00278174 · ClinicalTrials.gov registry record · Phase 2

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

A Phase 2 study of Kidney Cancer, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
Phase 2
Development phase
7
Enrollment target
1
Study location

NCT00278174 is a Phase 2 study of Kidney Cancer that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 7 participants, below the 880-participant average among 60 other Kidney Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00278174, a Phase 2 study of Kidney Cancer, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Interferon alfa may interfere with the growth of tumor cells and slow the growth of kidney cancer. PURPOSE: This phase II trial is studying how well interferon alfa works in treating patients with metastatic kidney cancer.

Conditions Studied

Kidney Cancer

Interventions

  • BIOLOGICAL recombinant interferon alpha-1b

Study Locations (1)

Ohio

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2005-02
Est. Completion 2007-04
Phase Phase 2

Sponsor

Case Comprehensive Cancer Center

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00278174

The ClinicalTrials.gov registry entry for NCT00278174 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 880-participant average among 60 other Kidney Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 1 intervention - of which recombinant interferon alpha-1b is the first listed.

NCT00278174 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00278174 about?

NCT00278174 is a clinical study titled "Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer". RATIONALE: Interferon alfa may interfere with the growth of tumor cells and slow the growth of kidney cancer. PURPOSE: This phase II trial is studying how well interferon alfa works in treating patients with metastatic kidney cancer.

What is the current status of trial NCT00278174?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2005-02. Estimated completion is 2007-04.

What conditions does trial NCT00278174 study?

This clinical trial studies the following conditions: Kidney Cancer.

What interventions are being tested in trial NCT00278174?

The interventions under investigation include: recombinant interferon alpha-1b (BIOLOGICAL).

Who is sponsoring clinical trial NCT00278174?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00278174 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.